Search
Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children
Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells Discover. Prevent. Cure. Abstract
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases Discover. Prevent. Cure. Antisense oligonucleotides (AOs)
News & Events
MRCF launches Perth-based biotech developing new treatment for Cystic FibrosisA The Kids Research Institute Australia spin-off company has received $20 million from the Medical Research Commercialisation Fund to develop a promising new therapy for the treatment of Cystic Fibrosis.
Lung inflammation and simulated airway resistance in infants with cystic fibrosis Discover. Prevent. Cure. Cystic fibrosis (CF) is characterized by
Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis Discover. Prevent. Cure. The solute carrier
Editorial: Emerging Therapeutic Approaches for Cystic Fibrosis Discover. Prevent. Cure. Editorial: Emerging Therapeutic Approaches for Cystic
Sialic acid-to-urea ratio as a measure of airway surface hydration. Discover. Prevent. Cure. Although airway mucus dehydration is key to
Multiple Breath Washout Cannot Be Used for Tidal Breath Parameter Analysis in Infants Discover. Prevent. Cure. Background: Multiple breath washout (
The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis Discover. Prevent. Cure. Lung inflammation